Transcription of Addendum to ICH E6 (R2)
{{id}} {{{paragraph}}}
11/23/201511 Addendum to ICH E6 (R2)Stephanie Shapley (US FDA) -RapporteurDr. Fergus Sweeney (EMA) -Regulatory ChairDate:December15, 2015 International Council for Harmonisationof Technical Requirementsfor Pharmaceuticals for Human UseLegal NoticeThis presentation is protected by copyright and may be used, reproduced, incorporated into other works, adapted, modified, translated or distributed under a public license provided that ICH's copyright in the presentation is acknowledged at all times. In case of any adaption, modification or translation of the presentation, reasonable steps must be taken to clearly label, demarcate or otherwise identify that changes were made to or based on the original presentation.
11/23/2015 8 Addendum Content o Sponsor responsibilities-Quality Management•risk-based approach to quality management, • Critical process & data identification • Risk Identification • Risk Evaluation
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}